SMOC1 and neoplasm: These genes are involved in antiviral defense mechanisms that may affect the progression of liver cancer, especially in patients with chronic hepatitis infections, where OAS gene activation could influence the hepatic immune response and alter the tumor microenvironment [26, 27].